Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon α in mice and guinea pigs

Veterinary Immunology and Immunopathology

Volumn 124, Issue 3-4, 2008, Pages 274-283

  Du, Yijun ^a   Dai, Jianjun ^a   Li, Yufeng ^a   Li, Congzhi ^b   Qi, Jing ^c   Duan, Shuyi ^a   Jiang, Ping ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b Shenlian Biomedical (Shanghai) Co Ltd   (China)

^c SHANDONG PEANUT RESEARCH INSTITUTE   (China)

Author keywords

FMDV; Interferon ; Recombinant adenovirus

Indexed keywords

ALPHA INTERFERON; HYBRID PROTEIN; PROTEIN VP1;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; FOOT AND MOUTH DISEASE VIRUS; GUINEA PIG; IMMUNE RESPONSE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CAPSID PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GUINEA PIGS; IMMUNIZATION; INTERFERON-ALPHA; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VACCINES, SYNTHETIC; VIRAL VACCINES;

ADENOVIRIDAE; ANIMALIA; CAVIA; FOOT-AND-MOUTH DISEASE VIRUS; MUS; SUIDAE; SUS;

EID: 47049097787     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.04.011     Document Type: Article

References (34)

1. Balamurugan V., Renji R., Venkatesh G., Reddy G.R., Nair S.P., Ganesh K., and Suryanarayana V.V.S. Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris. Arch. Virol. 150 (2005) 967-979
2. Barteling S.J., and Vreeswijk J. Developments in foot-and-mouth disease vaccines. Vaccine 9 (1991) 75-88
3. Belsham G.J. Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family, aspects of virus protein synthesis, protein processing and structure. Prog. Biophys. Mol. Biol. 60 (1993) 241-260
4. Berinstein A., Tami C., Taboga O., Smitsaart E., and Carrillo E. Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus. Vaccine 18 (2000) 2231-2238
5. Bittle J.L., Houghten R.A., Alexander H., Shinnick T.M., Suteliffe J.G., Lerner R.A., Rowlands D.J., and Brown F. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298 (1982) 30-35
6. Brown F. New approaches to vaccination against foot-and-mouth disease. Vaccine 10 (1992) 1022-1026
7. Chinsangaram J., Moraes M.P., Koster M., and Grubman M.J. Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease. J. Virol. 77 (2003) 1621-1625
8. Collen T., Dimarchi R., and Doel T.R. A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J. Immunol. 146 (1991) 749-755
9. Cull V.S., Broomfield S., Bartlett E.J., Brekalo N.L., and James C.M. Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice. Gene Ther. 9 (2002) 1369-1378
10. de Avila Botton S., Brum M.C.S., Bautista E., Koster M., Weiblen R., Golde W.T., and Grubman M.J. Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha. Vaccine 24 (2006) 3446-3456
11. Doel T.R. FMD vaccines. Virus Res. 91 (2003) 81-89
12. Guo H., Liu Z., Sun S., Bao H., Chen Y., Liu X., and Xie Q. Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99. Vaccine 23 (2005) 3236-3242
13. Jiang W., Jiang P., Li Y., Tang J., Wang X., and Ma S. Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice. Vet. Immunol. Immunopathol. 113 (2006) 169-180
14. Kaur R., Sachdeva G., and Vrati S. Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein. J. Infect. Dis. 185 (2002) 1-12
15. King A.M., Underwood B.O., McCahon D., Newman J.W., and Brown F. Biochemical identification of viruses causing the 1981 outbreaks of foot-and-mouth disease in the UK. Nature 293 (1981) 479-480
16. Le Bon A., Schiavoni G., D'Agostino G., Gresser I., Belardelli F., and Tough D.F. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14 (2001) 461-470
17. Mascola J.R., Sambor A., Beaudry K., Santra S., Welcher B., Louder M.K., Vancott T.C., Huang Y., Chakrabarti B.K., Kong W., Yang Z., Xu L., Montefiori D.C., Nabel G.J., and Letvin N.L. Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins. J. Virol. 79 (2005) 771-779
18. Mason P.W., Grubman M.J., and Baxt B. Molecular basis of pathogenesis of FMDV. Virus Res. 91 (2003) 9-32
19. Mayr G.A., Chinsangaram J., and Grubman M.J. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Virology 263 (1999) 496-506
20. Moraes M.P., Chinsangaram J., Brum M.C.S., and Grubman M.J. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 22 (2003) 268-279
21. Moraes M.P., Mayr G.A., Mason P.W., and Grubman M.J. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine 20 (2002) 1631-1639
22. Nandi S., Suryanarayana V.V.S., Banumathi N., and Sen A.K. Biochemical characterization of FMDV A10 and A22 subtypes by PAGE and IEF. Comp. Immun. Microbiol. Infect. Dis. 20 (1997) 95-99
23. Parry N.R., Fox G., Rowlands D., Brown F., Fry E., Acharya R., Logan D., and Stuart D. Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature 347 (1990) 569-572
24. Proietti E., Bracci L., Puzelli S., Di Pucchio T., Sestili P., De Vincenzi E., Venditti M., Capone I., Seif I., De Maeyer E., Tough D., Donatelli I., and Belardelli F. Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model. J. Immun. 169 (2002) 375-383
25. Qian P., Li X.M., Jin M.L., Peng G.Q., and Chen H.C. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine. Vaccine 22 (2004) 2129-2136
26. Saiz M., Nunez J.I., Jimenez-Clavero M.A., Baranowski E., and Sobrino F. Foot-and-mouth disease virus: biology and prospects for disease control. Microbes Infect. 4 11 (2002) 1183-1192
27. Shi X.J., Wang B., and Wang M. Immune enhancing effects of recombinant bovine IL-18 on foot-and-mouth disease vaccination in mice model. Vaccine 25 (2007) 1257-1264
28. Shi X.J., Wang B., Zhang C., and Wang M. Expression of BoIFN-γ and foot and mouth disease VP1 antigen in P. pastoris and their effects on mouse immune response to FMD antigens. Vaccine 24 (2006) 82-89
29. Van Lierop M.J.C., Van Maanen K., Meloen R.H., Rutten V.P.M.G., De Jong M.A.C., and Hensen E.J. Proliferative lymphocyte response to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle. Immunology 75 (1992) 406-413
30. Wesley R.D., Tang M., and Lager K.M. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. Vaccine 22 (2004) 3427-3434
31. Wigdorovitz A., Carrillo C., Dus Santos M.J., Trono K., Peralta A., Gomez M.C., Rios R.D., Franzone P.M., Sadir A.M., Escribano J.M., and Borca M.V. Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology 255 (1999) 347-353
32. Zhang H.Y., Sun S.H., Guo Y.J., Zhou F.J., Chen Z.H., Lin Y., and Shi K. Immune response in mice inoculated with plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus. Vaccine 21 (2003) 4704-4707
33. Zhang Z.D., Hutching G., Kitching P., and Alexandersen S. The effects of gamma interferon on replication of foot-and-mouth disease virus in persistently infected bovine cells. Arch. Virol. 147 (2002) 2157-2167
34. Zheng M., Jin N., Zhang H., Jin M., Lu H., Ma M., Li C., Yin G., Wang R., and Liu Q. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus. J. Virol. Methods 136 (2006) 230-237